0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Advances in Tumor Immunology and Immunotherapy (Paperback, Softcover reprint of the original 1st ed. 2014) Loot Price: R5,278
Discovery Miles 52 780
Advances in Tumor Immunology and Immunotherapy (Paperback, Softcover reprint of the original 1st ed. 2014): Joseph D....

Advances in Tumor Immunology and Immunotherapy (Paperback, Softcover reprint of the original 1st ed. 2014)

Joseph D. Rosenblatt, Eckhard R Podack, Glen N. Barber, Augusto Ochoa

Series: Current Cancer Research

 (sign in to rate)
Loot Price R5,278 Discovery Miles 52 780 | Repayment Terms: R495 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. Enhanced understanding of mechanisms underlying T-cell anergy such as arginine deprivation, immunosuppressive cytokines, defective innate and interferon response pathways, and NKG2D downregulation have all provided new insight into suppression of anti-tumor immunity and tumor evasion. In addition to emerging understanding of tumor evasion, new immune targets such as CTLA4 blockade, NK stimulatory receptors, manipulation of the antigen processing and presentation, cytokine and costimulatory responses all provide new possibilities for enhancing anti-tumor immunity even in tumors previously felt to be resistant to immune attack. Several of these strategies have already been realized in the clinic. The volume will explore evolving paradigms in antigen presentation, dendritic cell biology, the innate response and immunosuppressive mechanisms, and emerging strategies for manipulation of the immune system for therapeutic benefit that have realized success in neuroblastoma, leukemia, melanoma, lung cancer, and allogeneic transplantation. Early successes as well as failures will be highlighted to provide a snapshot of the state of clinical immunotherapy with an eye to future possibilities such as combination therapies, adoptive T-cell transfer, and the retargeting of immune cells via T-cell receptor engineering.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Current Cancer Research
Release date: August 2016
First published: 2014
Editors: Joseph D. Rosenblatt • Eckhard R Podack • Glen N. Barber • Augusto Ochoa
Dimensions: 235 x 155 x 25mm (L x W x T)
Format: Paperback
Pages: 371
Edition: Softcover reprint of the original 1st ed. 2014
ISBN-13: 978-1-4939-5097-3
Categories: Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 1-4939-5097-5
Barcode: 9781493950973

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners